▶ 調査レポート

徐放性ドラッグデリバリーシステムの世界市場(~2026年)

• 英文タイトル:Global Controlled-Release Drug Delivery Systems Market Insights and Forecast to 2026

QYResearchが調査・発行した産業分析レポートです。徐放性ドラッグデリバリーシステムの世界市場(~2026年) / Global Controlled-Release Drug Delivery Systems Market Insights and Forecast to 2026 / MRC2-11QY00618資料のイメージです。• レポートコード:MRC2-11QY00618
• 出版社/出版日:QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、110ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療、製薬
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は徐放性ドラッグデリバリーシステムのグローバル市場について調査・分析したレポートです。種類別(ワースターテクニック、コアセルベーション、マイクロカプセル化、インプラント、経皮、標的化送達、その他)市場規模、用途別(定量吸入器、注射剤、経皮・眼パッチ、輸液ポンプ、経口制御薬物送達システム、薬剤溶出ステント、その他)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別徐放性ドラッグデリバリーシステムの競争状況、市場シェア
・世界の徐放性ドラッグデリバリーシステム市場:種類別市場規模 2015年-2020年(ワースターテクニック、コアセルベーション、マイクロカプセル化、インプラント、経皮、標的化送達、その他)
・世界の徐放性ドラッグデリバリーシステム市場:種類別市場規模予測 2021年-2026年(ワースターテクニック、コアセルベーション、マイクロカプセル化、インプラント、経皮、標的化送達、その他)
・世界の徐放性ドラッグデリバリーシステム市場:用途別市場規模 2015年-2020年(定量吸入器、注射剤、経皮・眼パッチ、輸液ポンプ、経口制御薬物送達システム、薬剤溶出ステント、その他)
・世界の徐放性ドラッグデリバリーシステム市場:用途別市場規模予測 2021年-2026年(定量吸入器、注射剤、経皮・眼パッチ、輸液ポンプ、経口制御薬物送達システム、薬剤溶出ステント、その他)
・北米の徐放性ドラッグデリバリーシステム市場分析:米国、カナダ
・ヨーロッパの徐放性ドラッグデリバリーシステム市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの徐放性ドラッグデリバリーシステム市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の徐放性ドラッグデリバリーシステム市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの徐放性ドラッグデリバリーシステム市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Depomed, Inc.、Coating Place, Inc.、Corium International, Inc.、Johnson and Johnson、Alkermes plc、Pfizer, Inc.、Orbis Biosciences, Inc.、Capsugel、Merck and Co., Inc.、Aradigm Corporation
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Controlled-Release Drug Delivery Systems Market
The global Controlled-Release Drug Delivery Systems market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Controlled-Release Drug Delivery Systems Scope and Market Size
Controlled-Release Drug Delivery Systems market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Controlled-Release Drug Delivery Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Controlled-Release Drug Delivery Systems market is segmented into
Wurster Technique
Coacervation
Micro Encapsulation
Implants
Transdermal
Targeted Delivery
Others

Segment by Application, the Controlled-Release Drug Delivery Systems market is segmented into
Metered Dose Inhalers
Injectables
Transdermal and Ocular Patches
Infusion Pumps
Oral Controlled-Drug Delivery Systems
Drug Eluting Stents
Other

Regional and Country-level Analysis
The Controlled-Release Drug Delivery Systems market is analysed and market size information is provided by regions (countries).
The key regions covered in the Controlled-Release Drug Delivery Systems market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Controlled-Release Drug Delivery Systems Market Share Analysis
Controlled-Release Drug Delivery Systems market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Controlled-Release Drug Delivery Systems business, the date to enter into the Controlled-Release Drug Delivery Systems market, Controlled-Release Drug Delivery Systems product introduction, recent developments, etc.

The major vendors covered:
Depomed, Inc.
Coating Place, Inc.
Corium International, Inc.
Johnson and Johnson
Alkermes plc
Pfizer, Inc.
Orbis Biosciences, Inc.
Capsugel
Merck and Co., Inc.
Aradigm Corporation

レポート目次

1 Study Coverage
1.1 Controlled-Release Drug Delivery Systems Product Introduction
1.2 Market Segments
1.3 Key Controlled-Release Drug Delivery Systems Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Controlled-Release Drug Delivery Systems Market Size Growth Rate by Type
1.4.2 Wurster Technique
1.4.3 Coacervation
1.4.4 Micro Encapsulation
1.4.5 Implants
1.4.6 Transdermal
1.4.7 Targeted Delivery
1.4.8 Others
1.5 Market by Application
1.5.1 Global Controlled-Release Drug Delivery Systems Market Size Growth Rate by Application
1.5.2 Metered Dose Inhalers
1.5.3 Injectables
1.5.4 Transdermal and Ocular Patches
1.5.5 Infusion Pumps
1.5.6 Oral Controlled-Drug Delivery Systems
1.5.7 Drug Eluting Stents
1.5.8 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Controlled-Release Drug Delivery Systems Market Size, Estimates and Forecasts
2.1.1 Global Controlled-Release Drug Delivery Systems Revenue 2015-2026
2.1.2 Global Controlled-Release Drug Delivery Systems Sales 2015-2026
2.2 Global Controlled-Release Drug Delivery Systems, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Controlled-Release Drug Delivery Systems Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Controlled-Release Drug Delivery Systems Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Controlled-Release Drug Delivery Systems Competitor Landscape by Players
3.1 Controlled-Release Drug Delivery Systems Sales by Manufacturers
3.1.1 Controlled-Release Drug Delivery Systems Sales by Manufacturers (2015-2020)
3.1.2 Controlled-Release Drug Delivery Systems Sales Market Share by Manufacturers (2015-2020)
3.2 Controlled-Release Drug Delivery Systems Revenue by Manufacturers
3.2.1 Controlled-Release Drug Delivery Systems Revenue by Manufacturers (2015-2020)
3.2.2 Controlled-Release Drug Delivery Systems Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Controlled-Release Drug Delivery Systems Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Controlled-Release Drug Delivery Systems Revenue in 2019
3.2.5 Global Controlled-Release Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Controlled-Release Drug Delivery Systems Price by Manufacturers
3.4 Controlled-Release Drug Delivery Systems Manufacturing Base Distribution, Product Types
3.4.1 Controlled-Release Drug Delivery Systems Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Controlled-Release Drug Delivery Systems Product Type
3.4.3 Date of International Manufacturers Enter into Controlled-Release Drug Delivery Systems Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Controlled-Release Drug Delivery Systems Market Size by Type (2015-2020)
4.1.1 Global Controlled-Release Drug Delivery Systems Sales by Type (2015-2020)
4.1.2 Global Controlled-Release Drug Delivery Systems Revenue by Type (2015-2020)
4.1.3 Controlled-Release Drug Delivery Systems Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Controlled-Release Drug Delivery Systems Market Size Forecast by Type (2021-2026)
4.2.1 Global Controlled-Release Drug Delivery Systems Sales Forecast by Type (2021-2026)
4.2.2 Global Controlled-Release Drug Delivery Systems Revenue Forecast by Type (2021-2026)
4.2.3 Controlled-Release Drug Delivery Systems Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Controlled-Release Drug Delivery Systems Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Controlled-Release Drug Delivery Systems Market Size by Application (2015-2020)
5.1.1 Global Controlled-Release Drug Delivery Systems Sales by Application (2015-2020)
5.1.2 Global Controlled-Release Drug Delivery Systems Revenue by Application (2015-2020)
5.1.3 Controlled-Release Drug Delivery Systems Price by Application (2015-2020)
5.2 Controlled-Release Drug Delivery Systems Market Size Forecast by Application (2021-2026)
5.2.1 Global Controlled-Release Drug Delivery Systems Sales Forecast by Application (2021-2026)
5.2.2 Global Controlled-Release Drug Delivery Systems Revenue Forecast by Application (2021-2026)
5.2.3 Global Controlled-Release Drug Delivery Systems Price Forecast by Application (2021-2026)

6 North America
6.1 North America Controlled-Release Drug Delivery Systems by Country
6.1.1 North America Controlled-Release Drug Delivery Systems Sales by Country
6.1.2 North America Controlled-Release Drug Delivery Systems Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Controlled-Release Drug Delivery Systems Market Facts & Figures by Type
6.3 North America Controlled-Release Drug Delivery Systems Market Facts & Figures by Application

7 Europe
7.1 Europe Controlled-Release Drug Delivery Systems by Country
7.1.1 Europe Controlled-Release Drug Delivery Systems Sales by Country
7.1.2 Europe Controlled-Release Drug Delivery Systems Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Controlled-Release Drug Delivery Systems Market Facts & Figures by Type
7.3 Europe Controlled-Release Drug Delivery Systems Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Controlled-Release Drug Delivery Systems by Region
8.1.1 Asia Pacific Controlled-Release Drug Delivery Systems Sales by Region
8.1.2 Asia Pacific Controlled-Release Drug Delivery Systems Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Controlled-Release Drug Delivery Systems Market Facts & Figures by Type
8.3 Asia Pacific Controlled-Release Drug Delivery Systems Market Facts & Figures by Application

9 Latin America
9.1 Latin America Controlled-Release Drug Delivery Systems by Country
9.1.1 Latin America Controlled-Release Drug Delivery Systems Sales by Country
9.1.2 Latin America Controlled-Release Drug Delivery Systems Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Controlled-Release Drug Delivery Systems Market Facts & Figures by Type
9.3 Central & South America Controlled-Release Drug Delivery Systems Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Controlled-Release Drug Delivery Systems by Country
10.1.1 Middle East and Africa Controlled-Release Drug Delivery Systems Sales by Country
10.1.2 Middle East and Africa Controlled-Release Drug Delivery Systems Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Controlled-Release Drug Delivery Systems Market Facts & Figures by Type
10.3 Middle East and Africa Controlled-Release Drug Delivery Systems Market Facts & Figures by Application

11 Company Profiles
11.1 Depomed, Inc.
11.1.1 Depomed, Inc. Corporation Information
11.1.2 Depomed, Inc. Description and Business Overview
11.1.3 Depomed, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Depomed, Inc. Controlled-Release Drug Delivery Systems Products Offered
11.1.5 Depomed, Inc. Related Developments
11.2 Coating Place, Inc.
11.2.1 Coating Place, Inc. Corporation Information
11.2.2 Coating Place, Inc. Description and Business Overview
11.2.3 Coating Place, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Coating Place, Inc. Controlled-Release Drug Delivery Systems Products Offered
11.2.5 Coating Place, Inc. Related Developments
11.3 Corium International, Inc.
11.3.1 Corium International, Inc. Corporation Information
11.3.2 Corium International, Inc. Description and Business Overview
11.3.3 Corium International, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Corium International, Inc. Controlled-Release Drug Delivery Systems Products Offered
11.3.5 Corium International, Inc. Related Developments
11.4 Johnson and Johnson
11.4.1 Johnson and Johnson Corporation Information
11.4.2 Johnson and Johnson Description and Business Overview
11.4.3 Johnson and Johnson Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Johnson and Johnson Controlled-Release Drug Delivery Systems Products Offered
11.4.5 Johnson and Johnson Related Developments
11.5 Alkermes plc
11.5.1 Alkermes plc Corporation Information
11.5.2 Alkermes plc Description and Business Overview
11.5.3 Alkermes plc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Alkermes plc Controlled-Release Drug Delivery Systems Products Offered
11.5.5 Alkermes plc Related Developments
11.6 Pfizer, Inc.
11.6.1 Pfizer, Inc. Corporation Information
11.6.2 Pfizer, Inc. Description and Business Overview
11.6.3 Pfizer, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Pfizer, Inc. Controlled-Release Drug Delivery Systems Products Offered
11.6.5 Pfizer, Inc. Related Developments
11.7 Orbis Biosciences, Inc.
11.7.1 Orbis Biosciences, Inc. Corporation Information
11.7.2 Orbis Biosciences, Inc. Description and Business Overview
11.7.3 Orbis Biosciences, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Orbis Biosciences, Inc. Controlled-Release Drug Delivery Systems Products Offered
11.7.5 Orbis Biosciences, Inc. Related Developments
11.8 Capsugel
11.8.1 Capsugel Corporation Information
11.8.2 Capsugel Description and Business Overview
11.8.3 Capsugel Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Capsugel Controlled-Release Drug Delivery Systems Products Offered
11.8.5 Capsugel Related Developments
11.9 Merck and Co., Inc.
11.9.1 Merck and Co., Inc. Corporation Information
11.9.2 Merck and Co., Inc. Description and Business Overview
11.9.3 Merck and Co., Inc. Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Merck and Co., Inc. Controlled-Release Drug Delivery Systems Products Offered
11.9.5 Merck and Co., Inc. Related Developments
11.10 Aradigm Corporation
11.10.1 Aradigm Corporation Corporation Information
11.10.2 Aradigm Corporation Description and Business Overview
11.10.3 Aradigm Corporation Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Aradigm Corporation Controlled-Release Drug Delivery Systems Products Offered
11.10.5 Aradigm Corporation Related Developments
11.1 Depomed, Inc.
11.1.1 Depomed, Inc. Corporation Information
11.1.2 Depomed, Inc. Description and Business Overview
11.1.3 Depomed, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Depomed, Inc. Controlled-Release Drug Delivery Systems Products Offered
11.1.5 Depomed, Inc. Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Controlled-Release Drug Delivery Systems Market Estimates and Projections by Region
12.1.1 Global Controlled-Release Drug Delivery Systems Sales Forecast by Regions 2021-2026
12.1.2 Global Controlled-Release Drug Delivery Systems Revenue Forecast by Regions 2021-2026
12.2 North America Controlled-Release Drug Delivery Systems Market Size Forecast (2021-2026)
12.2.1 North America: Controlled-Release Drug Delivery Systems Sales Forecast (2021-2026)
12.2.2 North America: Controlled-Release Drug Delivery Systems Revenue Forecast (2021-2026)
12.2.3 North America: Controlled-Release Drug Delivery Systems Market Size Forecast by Country (2021-2026)
12.3 Europe Controlled-Release Drug Delivery Systems Market Size Forecast (2021-2026)
12.3.1 Europe: Controlled-Release Drug Delivery Systems Sales Forecast (2021-2026)
12.3.2 Europe: Controlled-Release Drug Delivery Systems Revenue Forecast (2021-2026)
12.3.3 Europe: Controlled-Release Drug Delivery Systems Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Controlled-Release Drug Delivery Systems Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Controlled-Release Drug Delivery Systems Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Controlled-Release Drug Delivery Systems Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Controlled-Release Drug Delivery Systems Market Size Forecast by Region (2021-2026)
12.5 Latin America Controlled-Release Drug Delivery Systems Market Size Forecast (2021-2026)
12.5.1 Latin America: Controlled-Release Drug Delivery Systems Sales Forecast (2021-2026)
12.5.2 Latin America: Controlled-Release Drug Delivery Systems Revenue Forecast (2021-2026)
12.5.3 Latin America: Controlled-Release Drug Delivery Systems Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Controlled-Release Drug Delivery Systems Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Controlled-Release Drug Delivery Systems Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Controlled-Release Drug Delivery Systems Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Controlled-Release Drug Delivery Systems Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Controlled-Release Drug Delivery Systems Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Controlled-Release Drug Delivery Systems Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Controlled-Release Drug Delivery Systems Market Segments
Table 2. Ranking of Global Top Controlled-Release Drug Delivery Systems Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Controlled-Release Drug Delivery Systems Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Wurster Technique
Table 5. Major Manufacturers of Coacervation
Table 6. Major Manufacturers of Micro Encapsulation
Table 7. Major Manufacturers of Implants
Table 8. Major Manufacturers of Transdermal
Table 9. Major Manufacturers of Targeted Delivery
Table 10. Major Manufacturers of Others
Table 11. Global Controlled-Release Drug Delivery Systems Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global Controlled-Release Drug Delivery Systems Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 13. Global Controlled-Release Drug Delivery Systems Sales by Regions 2015-2020 (K Units)
Table 14. Global Controlled-Release Drug Delivery Systems Sales Market Share by Regions (2015-2020)
Table 15. Global Controlled-Release Drug Delivery Systems Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Controlled-Release Drug Delivery Systems Sales by Manufacturers (2015-2020) (K Units)
Table 17. Global Controlled-Release Drug Delivery Systems Sales Share by Manufacturers (2015-2020)
Table 18. Global Controlled-Release Drug Delivery Systems Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Controlled-Release Drug Delivery Systems by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Controlled-Release Drug Delivery Systems as of 2019)
Table 20. Controlled-Release Drug Delivery Systems Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Controlled-Release Drug Delivery Systems Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Controlled-Release Drug Delivery Systems Price (2015-2020) (USD/Unit)
Table 23. Controlled-Release Drug Delivery Systems Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Controlled-Release Drug Delivery Systems Product Type
Table 25. Date of International Manufacturers Enter into Controlled-Release Drug Delivery Systems Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Controlled-Release Drug Delivery Systems Sales by Type (2015-2020) (K Units)
Table 28. Global Controlled-Release Drug Delivery Systems Sales Share by Type (2015-2020)
Table 29. Global Controlled-Release Drug Delivery Systems Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Controlled-Release Drug Delivery Systems Revenue Share by Type (2015-2020)
Table 31. Controlled-Release Drug Delivery Systems Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 32. Global Controlled-Release Drug Delivery Systems Sales by Application (2015-2020) (K Units)
Table 33. Global Controlled-Release Drug Delivery Systems Sales Share by Application (2015-2020)
Table 34. North America Controlled-Release Drug Delivery Systems Sales by Country (2015-2020) (K Units)
Table 35. North America Controlled-Release Drug Delivery Systems Sales Market Share by Country (2015-2020)
Table 36. North America Controlled-Release Drug Delivery Systems Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Controlled-Release Drug Delivery Systems Revenue Market Share by Country (2015-2020)
Table 38. North America Controlled-Release Drug Delivery Systems Sales by Type (2015-2020) (K Units)
Table 39. North America Controlled-Release Drug Delivery Systems Sales Market Share by Type (2015-2020)
Table 40. North America Controlled-Release Drug Delivery Systems Sales by Application (2015-2020) (K Units)
Table 41. North America Controlled-Release Drug Delivery Systems Sales Market Share by Application (2015-2020)
Table 42. Europe Controlled-Release Drug Delivery Systems Sales by Country (2015-2020) (K Units)
Table 43. Europe Controlled-Release Drug Delivery Systems Sales Market Share by Country (2015-2020)
Table 44. Europe Controlled-Release Drug Delivery Systems Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Controlled-Release Drug Delivery Systems Revenue Market Share by Country (2015-2020)
Table 46. Europe Controlled-Release Drug Delivery Systems Sales by Type (2015-2020) (K Units)
Table 47. Europe Controlled-Release Drug Delivery Systems Sales Market Share by Type (2015-2020)
Table 48. Europe Controlled-Release Drug Delivery Systems Sales by Application (2015-2020) (K Units)
Table 49. Europe Controlled-Release Drug Delivery Systems Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Controlled-Release Drug Delivery Systems Sales by Region (2015-2020) (K Units)
Table 51. Asia Pacific Controlled-Release Drug Delivery Systems Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Controlled-Release Drug Delivery Systems Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Controlled-Release Drug Delivery Systems Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Controlled-Release Drug Delivery Systems Sales by Type (2015-2020) (K Units)
Table 55. Asia Pacific Controlled-Release Drug Delivery Systems Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Controlled-Release Drug Delivery Systems Sales by Application (2015-2020) (K Units)
Table 57. Asia Pacific Controlled-Release Drug Delivery Systems Sales Market Share by Application (2015-2020)
Table 58. Latin America Controlled-Release Drug Delivery Systems Sales by Country (2015-2020) (K Units)
Table 59. Latin America Controlled-Release Drug Delivery Systems Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Controlled-Release Drug Delivery Systems Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Controlled-Release Drug Delivery Systems Revenue Market Share by Country (2015-2020)
Table 62. Latin America Controlled-Release Drug Delivery Systems Sales by Type (2015-2020) (K Units)
Table 63. Latin America Controlled-Release Drug Delivery Systems Sales Market Share by Type (2015-2020)
Table 64. Latin America Controlled-Release Drug Delivery Systems Sales by Application (2015-2020) (K Units)
Table 65. Latin America Controlled-Release Drug Delivery Systems Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Controlled-Release Drug Delivery Systems Sales by Country (2015-2020) (K Units)
Table 67. Middle East and Africa Controlled-Release Drug Delivery Systems Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Controlled-Release Drug Delivery Systems Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Controlled-Release Drug Delivery Systems Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Controlled-Release Drug Delivery Systems Sales by Type (2015-2020) (K Units)
Table 71. Middle East and Africa Controlled-Release Drug Delivery Systems Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Controlled-Release Drug Delivery Systems Sales by Application (2015-2020) (K Units)
Table 73. Middle East and Africa Controlled-Release Drug Delivery Systems Sales Market Share by Application (2015-2020)
Table 74. Depomed, Inc. Corporation Information
Table 75. Depomed, Inc. Description and Major Businesses
Table 76. Depomed, Inc. Controlled-Release Drug Delivery Systems Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Depomed, Inc. Product
Table 78. Depomed, Inc. Recent Development
Table 79. Coating Place, Inc. Corporation Information
Table 80. Coating Place, Inc. Description and Major Businesses
Table 81. Coating Place, Inc. Controlled-Release Drug Delivery Systems Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Coating Place, Inc. Product
Table 83. Coating Place, Inc. Recent Development
Table 84. Corium International, Inc. Corporation Information
Table 85. Corium International, Inc. Description and Major Businesses
Table 86. Corium International, Inc. Controlled-Release Drug Delivery Systems Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Corium International, Inc. Product
Table 88. Corium International, Inc. Recent Development
Table 89. Johnson and Johnson Corporation Information
Table 90. Johnson and Johnson Description and Major Businesses
Table 91. Johnson and Johnson Controlled-Release Drug Delivery Systems Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Johnson and Johnson Product
Table 93. Johnson and Johnson Recent Development
Table 94. Alkermes plc Corporation Information
Table 95. Alkermes plc Description and Major Businesses
Table 96. Alkermes plc Controlled-Release Drug Delivery Systems Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Alkermes plc Product
Table 98. Alkermes plc Recent Development
Table 99. Pfizer, Inc. Corporation Information
Table 100. Pfizer, Inc. Description and Major Businesses
Table 101. Pfizer, Inc. Controlled-Release Drug Delivery Systems Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Pfizer, Inc. Product
Table 103. Pfizer, Inc. Recent Development
Table 104. Orbis Biosciences, Inc. Corporation Information
Table 105. Orbis Biosciences, Inc. Description and Major Businesses
Table 106. Orbis Biosciences, Inc. Controlled-Release Drug Delivery Systems Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Orbis Biosciences, Inc. Product
Table 108. Orbis Biosciences, Inc. Recent Development
Table 109. Capsugel Corporation Information
Table 110. Capsugel Description and Major Businesses
Table 111. Capsugel Controlled-Release Drug Delivery Systems Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Capsugel Product
Table 113. Capsugel Recent Development
Table 114. Merck and Co., Inc. Corporation Information
Table 115. Merck and Co., Inc. Description and Major Businesses
Table 116. Merck and Co., Inc. Controlled-Release Drug Delivery Systems Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Merck and Co., Inc. Product
Table 118. Merck and Co., Inc. Recent Development
Table 119. Aradigm Corporation Corporation Information
Table 120. Aradigm Corporation Description and Major Businesses
Table 121. Aradigm Corporation Controlled-Release Drug Delivery Systems Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Aradigm Corporation Product
Table 123. Aradigm Corporation Recent Development
Table 124. Global Controlled-Release Drug Delivery Systems Sales Forecast by Regions (2021-2026) (K Units)
Table 125. Global Controlled-Release Drug Delivery Systems Sales Market Share Forecast by Regions (2021-2026)
Table 126. Global Controlled-Release Drug Delivery Systems Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 127. Global Controlled-Release Drug Delivery Systems Revenue Market Share Forecast by Regions (2021-2026)
Table 128. North America: Controlled-Release Drug Delivery Systems Sales Forecast by Country (2021-2026) (K Units)
Table 129. North America: Controlled-Release Drug Delivery Systems Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Europe: Controlled-Release Drug Delivery Systems Sales Forecast by Country (2021-2026) (K Units)
Table 131. Europe: Controlled-Release Drug Delivery Systems Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Asia Pacific: Controlled-Release Drug Delivery Systems Sales Forecast by Region (2021-2026) (K Units)
Table 133. Asia Pacific: Controlled-Release Drug Delivery Systems Revenue Forecast by Region (2021-2026) (US$ Million)
Table 134. Latin America: Controlled-Release Drug Delivery Systems Sales Forecast by Country (2021-2026) (K Units)
Table 135. Latin America: Controlled-Release Drug Delivery Systems Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Middle East and Africa: Controlled-Release Drug Delivery Systems Sales Forecast by Country (2021-2026) (K Units)
Table 137. Middle East and Africa: Controlled-Release Drug Delivery Systems Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 139. Key Challenges
Table 140. Market Risks
Table 141. Main Points Interviewed from Key Controlled-Release Drug Delivery Systems Players
Table 142. Controlled-Release Drug Delivery Systems Customers List
Table 143. Controlled-Release Drug Delivery Systems Distributors List
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Controlled-Release Drug Delivery Systems Product Picture
Figure 2. Global Controlled-Release Drug Delivery Systems Sales Market Share by Type in 2020 & 2026
Figure 3. Wurster Technique Product Picture
Figure 4. Coacervation Product Picture
Figure 5. Micro Encapsulation Product Picture
Figure 6. Implants Product Picture
Figure 7. Transdermal Product Picture
Figure 8. Targeted Delivery Product Picture
Figure 9. Others Product Picture
Figure 10. Global Controlled-Release Drug Delivery Systems Sales Market Share by Application in 2020 & 2026
Figure 11. Metered Dose Inhalers
Figure 12. Injectables
Figure 13. Transdermal and Ocular Patches
Figure 14. Infusion Pumps
Figure 15. Oral Controlled-Drug Delivery Systems
Figure 16. Drug Eluting Stents
Figure 17. Other
Figure 18. Controlled-Release Drug Delivery Systems Report Years Considered
Figure 19. Global Controlled-Release Drug Delivery Systems Market Size 2015-2026 (US$ Million)
Figure 20. Global Controlled-Release Drug Delivery Systems Sales 2015-2026 (K Units)
Figure 21. Global Controlled-Release Drug Delivery Systems Market Size Market Share by Region: 2020 Versus 2026
Figure 22. Global Controlled-Release Drug Delivery Systems Sales Market Share by Region (2015-2020)
Figure 23. Global Controlled-Release Drug Delivery Systems Sales Market Share by Region in 2019
Figure 24. Global Controlled-Release Drug Delivery Systems Revenue Market Share by Region (2015-2020)
Figure 25. Global Controlled-Release Drug Delivery Systems Revenue Market Share by Region in 2019
Figure 26. Global Controlled-Release Drug Delivery Systems Sales Share by Manufacturer in 2019
Figure 27. The Top 10 and 5 Players Market Share by Controlled-Release Drug Delivery Systems Revenue in 2019
Figure 28. Controlled-Release Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Controlled-Release Drug Delivery Systems Sales Market Share by Type (2015-2020)
Figure 30. Global Controlled-Release Drug Delivery Systems Sales Market Share by Type in 2019
Figure 31. Global Controlled-Release Drug Delivery Systems Revenue Market Share by Type (2015-2020)
Figure 32. Global Controlled-Release Drug Delivery Systems Revenue Market Share by Type in 2019
Figure 33. Global Controlled-Release Drug Delivery Systems Market Share by Price Range (2015-2020)
Figure 34. Global Controlled-Release Drug Delivery Systems Sales Market Share by Application (2015-2020)
Figure 35. Global Controlled-Release Drug Delivery Systems Sales Market Share by Application in 2019
Figure 36. Global Controlled-Release Drug Delivery Systems Revenue Market Share by Application (2015-2020)
Figure 37. Global Controlled-Release Drug Delivery Systems Revenue Market Share by Application in 2019
Figure 38. North America Controlled-Release Drug Delivery Systems Sales Growth Rate 2015-2020 (K Units)
Figure 39. North America Controlled-Release Drug Delivery Systems Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. North America Controlled-Release Drug Delivery Systems Sales Market Share by Country in 2019
Figure 41. North America Controlled-Release Drug Delivery Systems Revenue Market Share by Country in 2019
Figure 42. U.S. Controlled-Release Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 43. U.S. Controlled-Release Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Canada Controlled-Release Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 45. Canada Controlled-Release Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. North America Controlled-Release Drug Delivery Systems Market Share by Type in 2019
Figure 47. North America Controlled-Release Drug Delivery Systems Market Share by Application in 2019
Figure 48. Europe Controlled-Release Drug Delivery Systems Sales Growth Rate 2015-2020 (K Units)
Figure 49. Europe Controlled-Release Drug Delivery Systems Revenue Growth Rate 2015-2020 (US$ Million)
Figure 50. Europe Controlled-Release Drug Delivery Systems Sales Market Share by Country in 2019
Figure 51. Europe Controlled-Release Drug Delivery Systems Revenue Market Share by Country in 2019
Figure 52. Germany Controlled-Release Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 53. Germany Controlled-Release Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. France Controlled-Release Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 55. France Controlled-Release Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. U.K. Controlled-Release Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 57. U.K. Controlled-Release Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Italy Controlled-Release Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 59. Italy Controlled-Release Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Russia Controlled-Release Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 61. Russia Controlled-Release Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Europe Controlled-Release Drug Delivery Systems Market Share by Type in 2019
Figure 63. Europe Controlled-Release Drug Delivery Systems Market Share by Application in 2019
Figure 64. Asia Pacific Controlled-Release Drug Delivery Systems Sales Growth Rate 2015-2020 (K Units)
Figure 65. Asia Pacific Controlled-Release Drug Delivery Systems Revenue Growth Rate 2015-2020 (US$ Million)
Figure 66. Asia Pacific Controlled-Release Drug Delivery Systems Sales Market Share by Region in 2019
Figure 67. Asia Pacific Controlled-Release Drug Delivery Systems Revenue Market Share by Region in 2019
Figure 68. China Controlled-Release Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 69. China Controlled-Release Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Japan Controlled-Release Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 71. Japan Controlled-Release Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. South Korea Controlled-Release Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 73. South Korea Controlled-Release Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. India Controlled-Release Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 75. India Controlled-Release Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Australia Controlled-Release Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 77. Australia Controlled-Release Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Taiwan Controlled-Release Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 79. Taiwan Controlled-Release Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Indonesia Controlled-Release Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 81. Indonesia Controlled-Release Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Thailand Controlled-Release Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 83. Thailand Controlled-Release Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Malaysia Controlled-Release Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 85. Malaysia Controlled-Release Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Philippines Controlled-Release Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 87. Philippines Controlled-Release Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Vietnam Controlled-Release Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 89. Vietnam Controlled-Release Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Asia Pacific Controlled-Release Drug Delivery Systems Market Share by Type in 2019
Figure 91. Asia Pacific Controlled-Release Drug Delivery Systems Market Share by Application in 2019
Figure 92. Latin America Controlled-Release Drug Delivery Systems Sales Growth Rate 2015-2020 (K Units)
Figure 93. Latin America Controlled-Release Drug Delivery Systems Revenue Growth Rate 2015-2020 (US$ Million)
Figure 94. Latin America Controlled-Release Drug Delivery Systems Sales Market Share by Country in 2019
Figure 95. Latin America Controlled-Release Drug Delivery Systems Revenue Market Share by Country in 2019
Figure 96. Mexico Controlled-Release Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 97. Mexico Controlled-Release Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Brazil Controlled-Release Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 99. Brazil Controlled-Release Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Argentina Controlled-Release Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 101. Argentina Controlled-Release Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Latin America Controlled-Release Drug Delivery Systems Market Share by Type in 2019
Figure 103. Latin America Controlled-Release Drug Delivery Systems Market Share by Application in 2019
Figure 104. Middle East and Africa Controlled-Release Drug Delivery Systems Sales Growth Rate 2015-2020 (K Units)
Figure 105. Middle East and Africa Controlled-Release Drug Delivery Systems Revenue Growth Rate 2015-2020 (US$ Million)
Figure 106. Middle East and Africa Controlled-Release Drug Delivery Systems Sales Market Share by Country in 2019
Figure 107. Middle East and Africa Controlled-Release Drug Delivery Systems Revenue Market Share by Country in 2019
Figure 108. Turkey Controlled-Release Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 109. Turkey Controlled-Release Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Saudi Arabia Controlled-Release Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 111. Saudi Arabia Controlled-Release Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 112. U.A.E Controlled-Release Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 113. U.A.E Controlled-Release Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 114. Middle East and Africa Controlled-Release Drug Delivery Systems Market Share by Type in 2019
Figure 115. Middle East and Africa Controlled-Release Drug Delivery Systems Market Share by Application in 2019
Figure 116. North America Controlled-Release Drug Delivery Systems Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. North America Controlled-Release Drug Delivery Systems Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Europe Controlled-Release Drug Delivery Systems Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Europe Controlled-Release Drug Delivery Systems Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Asia Pacific Controlled-Release Drug Delivery Systems Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. Asia Pacific Controlled-Release Drug Delivery Systems Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Latin America Controlled-Release Drug Delivery Systems Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 123. Latin America Controlled-Release Drug Delivery Systems Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Middle East and Africa Controlled-Release Drug Delivery Systems Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 125. Middle East and Africa Controlled-Release Drug Delivery Systems Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Porter's Five Forces Analysis
Figure 127. Channels of Distribution
Figure 128. Distributors Profiles
Figure 129. Bottom-up and Top-down Approaches for This Report
Figure 130. Data Triangulation
Figure 131. Key Executives Interviewed